Aadi bioscience to participate at upcoming investor conferences

Los angeles , sept. 5, 2023 /prnewswire/ -- aadi bioscience, inc. (nasdaq: aadi), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers with mtor pathway alterations, announced today participation at the following investor events: h.c.
AADI Ratings Summary
AADI Quant Ranking